MedicaidPrior AuthLow impact
Ixempra (ixabepilone) (New)
Humana·LA · Oncology, Hematology·Medicaid
Effective date
Nov 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicaid Louisiana has implemented a new prior authorization policy for Ixempra (ixabepilone), a chemotherapy drug for advanced/metastatic breast cancer. The policy requires specific criteria including resistance to other cancer treatments and excludes patients with severe hypersensitivity reactions or liver impairment.
Action Required
By November 1, 2025: Billing team must update prior authorization workflows for Ixempra (ixabepilone) prescriptions for Humana Medicaid Louisiana members. Ensure documentation includes diagnosis of locally advanced/metastatic breast cancer, previous treatment failures (anthracycline, taxane, capecitabine), and absence of contraindications. Claims will require prior authorization approval before processing.